The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 56,378 | 965,369 | SH | DFND | 1 | 0 | 965,369 | 0 | |
| ELEVEN BIOTHERAPEUTICS INC | COM | 286221106 | 2,268 | 1,030,884 | SH | DFND | 1 | 0 | 1,030,884 | 0 | |
| ELEVEN BIOTHERAPEUTICS INC | COM | 286221106 | 645 | 293,134 | SH | DFND | 2 | 0 | 293,134 | 0 | |
| T2 BIOSYSTEMS INC | COM | 89853L104 | 8,589 | 1,632,816 | SH | DFND | 0 | 1,632,816 | 0 | ||
| T2 BIOSYSTEMS INC | COM | 89853L104 | 1,671 | 317,767 | SH | DFND | 2 | 0 | 317,767 | 0 | |
| SERES THERAPEUTICS INC | COM | 81750R102 | 142,936 | 12,682,876 | SH | DFND | 2 | 0 | 12,682,876 | 0 | |
| EDITAS MEDICINE INC | COM | 28106W103 | 75,356 | 3,376,184 | SH | DFND | 2 | 0 | 3,376,184 | 0 | |
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 76,570 | 4,806,656 | SH | DFND | 2 | 0 | 4,806,656 | 0 | |
| SELECTA BIOSCIENCES INC | COM | 816212104 | 11,841 | 826,862 | SH | DFND | 1 | 0 | 826,862 | 0 | |